Table 3. Subgroup analysis for questionnaire responses, completed immediately after an IVT injection.

Questions	Answer	Previous injection(s)			CDVA				Injected agent			Pathology			Lens status
		No previous injection (n=30)	Previous injections (n=45)	P-value	Good CDVA (n=35)	Moderate CDVA (n=23)	Poor CDVA (n=17)	P-value	Clear agent (n=69)	Suspension (n=6)	P-value	CNV (n=62)	MO (n=13)	P-value	Phakic (n=33)	Pseudophakic (n=41)	P-value
Do you see lights?	Yes	8 (27%)	12 (27%)	1.0	9 (26%)	5 (23%)	6 (35%)	0.62	19 (28%)	1 (17%)	0.56	17 (27%)	3 (23%)	0.75	7 (21%)	12 (29%)	0.43
Do you see floaters?	Yes	9 (30%)	15 (33%)	0.76	12 (34%)	6 (26%)	6 (35%)	0.76	20 (29%)	4 (67%)	0.06	17 (27%)	7 (54%)	0.06	11 (33%)	13 (32%)	0.88
Vision now compared with vision before the injection	Better	2 (7%)	5 (11%)	0.24	1 (3%)	3 (13%)	3 (8%)	0.24	7 (10%)	0	0.30	6 (10%)	1 (8%)	0.00	2 (6%)	5 (12%)	0.42
	Worse	23 (77%)	26 (58%)		25 (71%)	16 (70%)	23 (64%)		46 (65%)	3 (50%)		45 (73%)	4 (41%)		24 (73%)	24 (59%)
	Same	5 (16%)	14 (31%)		9 (26%)	4 (17%)	10 (28%)		16 (23%)	3 (50%)		11 (18%)	8 (62%)		7 (21%)	12 (29%)

Abbreviations: CDVA, corrected distance visual acuity; CNV, choroidal neovascular membrane; IVT, intravitreous; MO, macular edema.

Good CDVA (≤0.3); moderate CDVA (>0.3 and <0.7) and poor CDVA (≥0.7).